Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Year-over-year book value per share growth
Percentile
P59
Within normal range
vs 3Y Ago
-1.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -7.44% |
| Q3 2025 | -6.56% |
| Q2 2025 | -7.38% |
| Q1 2025 | -5.33% |
| Q4 2024 | -5.63% |
| Q3 2024 | 145.68% |
| Q2 2024 | -11.87% |
| Q1 2024 | -9.06% |
| Q4 2023 | -8.70% |
| Q3 2023 | -8.53% |
| Q2 2023 | -7.62% |
| Q1 2023 | -6.40% |
| Q4 2022 | 4.93% |
| Q3 2022 | -6.65% |
| Q2 2022 | -7.47% |
| Q1 2022 | -6.77% |
| Q4 2021 | -2.74% |
| Q3 2021 | -13.29% |
| Q2 2021 | -14.62% |
| Q1 2021 | 472.62% |
| Q4 2020 | -17.00% |
| Q3 2020 | -14.20% |
| Q2 2020 | -11.14% |
| Q1 2020 | -9.01% |
| Q4 2019 | 31.38% |
| Q3 2019 | -15.96% |
| Q2 2019 | -14.51% |
| Q1 2019 | -10.19% |
| Q4 2018 | -9.80% |
| Q3 2018 | -8.14% |
| Q2 2018 | -8.24% |
| Q1 2018 | 101.87% |
| Q4 2017 | -17.06% |
| Q3 2017 | -14.75% |
| Q2 2017 | 49.77% |
| Q1 2017 | -14.63% |
| Q4 2016 | -18.23% |
| Q3 2016 | 36.74% |
| Q2 2016 | -13.24% |
| Q1 2016 | -4.21% |